6 results on '"Glinka P"'
Search Results
2. Now is the Time to Study the Timing of Influenza Vaccine.
- Author
-
Glinka, ER, Smith, DM, and Johns, ST
- Subjects
Humans ,HIV ,HIV Infections ,Influenza Vaccines ,Vaccination ,Influenza ,Human ,Clinical Sciences ,Virology - Published
- 2018
3. Angiopoietin-like 4 Is a Wnt Signaling Antagonist that Promotes LRP6 Turnover
- Author
-
Kirsch, Nadine, Chang, Ling-Shih, Koch, Stefan, Glinka, Andrey, Dolde, Christine, Colozza, Gabriele, Benitez, Maria DJ, De Robertis, Edward M, and Niehrs, Christof
- Subjects
Biochemistry and Cell Biology ,Biological Sciences ,Aetiology ,2.1 Biological and endogenous factors ,Angiopoietin-Like Protein 4 ,Angiopoietins ,Animals ,Endocytosis ,Humans ,Low Density Lipoprotein Receptor-Related Protein-6 ,Phosphorylation ,Receptors ,LDL ,Signal Transduction ,Wnt Signaling Pathway ,Wnt3A Protein ,Xenopus ,Xenopus Proteins ,beta Catenin ,LRP6 ,Wnt/β-catenin signaling ,angiopoietin-like 4 ,syndecan ,Medical and Health Sciences ,Developmental Biology ,Biochemistry and cell biology - Abstract
Angiopoietin-like 4 (ANGPTL4) is a secreted signaling protein that is implicated in cardiovascular disease, metabolic disorder, and cancer. Outside of its role in lipid metabolism, ANGPTL4 signaling remains poorly understood. Here, we identify ANGPTL4 as a Wnt signaling antagonist that binds to syndecans and forms a ternary complex with the Wnt co-receptor Lipoprotein receptor-related protein 6 (LRP6). This protein complex is internalized via clathrin-mediated endocytosis and degraded in lysosomes, leading to attenuation of Wnt/β-catenin signaling. Angptl4 is expressed in the Spemann organizer of Xenopus embryos and acts as a Wnt antagonist to promote notochord formation and prevent muscle differentiation. This unexpected function of ANGPTL4 invites re-interpretation of its diverse physiological effects in light of Wnt signaling and may open therapeutic avenues for human disease.
- Published
- 2017
4. Angiopoietin-like 4 Is a Wnt Signaling Antagonist that Promotes LRP6 Turnover.
- Author
-
Kirsch, Nadine, Chang, Ling-Shih, Koch, Stefan, Glinka, Andrey, Dolde, Christine, Colozza, Gabriele, Benitez, Maria DJ, De Robertis, Edward M, and Niehrs, Christof
- Subjects
Animals ,Xenopus ,Humans ,Angiopoietins ,Xenopus Proteins ,Receptors ,LDL ,Signal Transduction ,Endocytosis ,Phosphorylation ,beta Catenin ,Low Density Lipoprotein Receptor-Related Protein-6 ,Wnt3A Protein ,Wnt Signaling Pathway ,Angiopoietin-like 4 Protein ,LRP6 ,Wnt/β-catenin signaling ,angiopoietin-like 4 ,syndecan ,Developmental Biology ,Biological Sciences ,Medical and Health Sciences - Abstract
Angiopoietin-like 4 (ANGPTL4) is a secreted signaling protein that is implicated in cardiovascular disease, metabolic disorder, and cancer. Outside of its role in lipid metabolism, ANGPTL4 signaling remains poorly understood. Here, we identify ANGPTL4 as a Wnt signaling antagonist that binds to syndecans and forms a ternary complex with the Wnt co-receptor Lipoprotein receptor-related protein 6 (LRP6). This protein complex is internalized via clathrin-mediated endocytosis and degraded in lysosomes, leading to attenuation of Wnt/β-catenin signaling. Angptl4 is expressed in the Spemann organizer of Xenopus embryos and acts as a Wnt antagonist to promote notochord formation and prevent muscle differentiation. This unexpected function of ANGPTL4 invites re-interpretation of its diverse physiological effects in light of Wnt signaling and may open therapeutic avenues for human disease.
- Published
- 2017
5. Timing Matters ‐ Influenza Vaccination to HIV‐Infected Patients
- Author
-
Glinka, ER, Smith, DM, and Johns, ST
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Clinical Sciences ,Infectious Diseases ,Pneumonia & Influenza ,Prevention ,Influenza ,Sexually Transmitted Infections ,HIV/AIDS ,Immunization ,Emerging Infectious Diseases ,Vaccine Related ,3.4 Vaccines ,6.1 Pharmaceuticals ,Infection ,Good Health and Well Being ,Adult ,Aged ,Female ,HIV Infections ,Humans ,Immunization Schedule ,Incidence ,Influenza Vaccines ,Influenza ,Human ,Male ,Middle Aged ,Retrospective Studies ,United States ,HIV ,influenza ,influenza-like illness ,timing ,vaccination ,Virology ,Clinical sciences ,Epidemiology - Abstract
ObjectivesPatients with HIV infection vaccinated early in the flu season are more likely to contract influenza or influenza-like illness (ILI) compared with those receiving late vaccination. It is known that antibody titres wane over time, particularly among individuals with HIV infection. It is unclear if the timing of influenza vaccination within the flu season affects the probability of an influenza infection later during the flu season. The aim of this study is to evaluate if there is a relationship between the timing of influenza vaccination and incidence of influenza or ILI in patients with HIV infection.MethodsA retrospective cohort study of HIV-infected patients in care at the Department of Veterans Affairs San Diego Healthcare System was conducted from 1 September 2005 to 31 May 2013. Among these patients, we evaluated whether there was a relationship between the timing of influenza vaccination and the incidence of laboratory-confirmed influenza, influenza diagnosed by a physician, or ILI.ResultsPatients who received influenza vaccine early in the season were more likely to contract influenza or ILI than patients who were vaccinated late (P < 0.01). Vaccinated patients who developed influenza or ILI were more likely to do so later in the season (P < 0.01).ConclusionsHIV-infected patients vaccinated early in the flu season were more likely to contract influenza or ILI than those vaccinated later in the season.
- Published
- 2016
6. Timing Matters - Influenza Vaccination to HIV-Infected Patients.
- Author
-
Glinka, ER, Smith, DM, and Johns, ST
- Subjects
Humans ,HIV Infections ,Influenza Vaccines ,Immunization Schedule ,Incidence ,Retrospective Studies ,Adult ,Aged ,Middle Aged ,United States ,Female ,Male ,Influenza ,Human ,HIV ,influenza ,influenza-like illness ,timing ,vaccination ,Influenza ,Human ,Biodefense ,Prevention ,Pneumonia & Influenza ,Emerging Infectious Diseases ,Vaccine Related ,Immunization ,Clinical Research ,HIV/AIDS ,Infectious Diseases ,6.1 Pharmaceuticals ,3.4 Vaccines ,Infection ,Clinical Sciences ,Virology - Abstract
ObjectivesPatients with HIV infection vaccinated early in the flu season are more likely to contract influenza or influenza-like illness (ILI) compared with those receiving late vaccination. It is known that antibody titres wane over time, particularly among individuals with HIV infection. It is unclear if the timing of influenza vaccination within the flu season affects the probability of an influenza infection later during the flu season. The aim of this study is to evaluate if there is a relationship between the timing of influenza vaccination and incidence of influenza or ILI in patients with HIV infection.MethodsA retrospective cohort study of HIV-infected patients in care at the Department of Veterans Affairs San Diego Healthcare System was conducted from 1 September 2005 to 31 May 2013. Among these patients, we evaluated whether there was a relationship between the timing of influenza vaccination and the incidence of laboratory-confirmed influenza, influenza diagnosed by a physician, or ILI.ResultsPatients who received influenza vaccine early in the season were more likely to contract influenza or ILI than patients who were vaccinated late (P < 0.01). Vaccinated patients who developed influenza or ILI were more likely to do so later in the season (P < 0.01).ConclusionsHIV-infected patients vaccinated early in the flu season were more likely to contract influenza or ILI than those vaccinated later in the season.
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.